nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000649	0.000649	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—C3—age related macular degeneration	0.000649	0.000649	CbGpPWpGaD
Doxepin—CHRM5—GPCR downstream signaling—C3—age related macular degeneration	0.000646	0.000646	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—C3—age related macular degeneration	0.000645	0.000645	CbGpPWpGaD
Doxepin—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000643	0.000643	CbGpPWpGaD
Doxepin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000641	0.000641	CbGpPWpGaD
Doxepin—HTR2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000633	0.000633	CbGpPWpGaD
Doxepin—HRH1—GPCR ligand binding—CCL2—age related macular degeneration	0.000631	0.000631	CbGpPWpGaD
Doxepin—CHRM1—GPCR ligand binding—CCL2—age related macular degeneration	0.000629	0.000629	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFBR1—age related macular degeneration	0.000628	0.000628	CbGpPWpGaD
Doxepin—CHRM3—GPCR ligand binding—CCL2—age related macular degeneration	0.000627	0.000627	CbGpPWpGaD
Doxepin—CHRM2—GPCR ligand binding—CCL2—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Doxepin—ADRA1A—GPCR ligand binding—CCL2—age related macular degeneration	0.00062	0.00062	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000618	0.000618	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000613	0.000613	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—C3—age related macular degeneration	0.000612	0.000612	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000608	0.000608	CbGpPWpGaD
Doxepin—ADRA1D—GPCR downstream signaling—C3—age related macular degeneration	0.000607	0.000607	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—SQSTM1—age related macular degeneration	0.000603	0.000603	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000602	0.000602	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFBR1—age related macular degeneration	0.000601	0.000601	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—APOE—age related macular degeneration	0.0006	0.0006	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—LIPC—age related macular degeneration	0.000598	0.000598	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—C3—age related macular degeneration	0.000592	0.000592	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—KDR—age related macular degeneration	0.000588	0.000588	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—C3—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000581	0.000581	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—CETP—age related macular degeneration	0.000577	0.000577	CbGpPWpGaD
Doxepin—ADRA2A—GPCR ligand binding—CCL2—age related macular degeneration	0.000576	0.000576	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000573	0.000573	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—SQSTM1—age related macular degeneration	0.000569	0.000569	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFBR1—age related macular degeneration	0.000565	0.000565	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—C3—age related macular degeneration	0.000551	0.000551	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000551	0.000551	CbGpPWpGaD
Doxepin—ADRA2B—GPCR downstream signaling—C3—age related macular degeneration	0.000548	0.000548	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—SQSTM1—age related macular degeneration	0.000545	0.000545	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—LIPC—age related macular degeneration	0.000529	0.000529	CbGpPWpGaD
Doxepin—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000529	0.000529	CbGpPWpGaD
Doxepin—HTR2C—GPCR downstream signaling—C3—age related macular degeneration	0.000526	0.000526	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000523	0.000523	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—SQSTM1—age related macular degeneration	0.000513	0.000513	CbGpPWpGaD
Doxepin—ADRA2C—GPCR downstream signaling—C3—age related macular degeneration	0.000512	0.000512	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—CETP—age related macular degeneration	0.00051	0.00051	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFBR1—age related macular degeneration	0.00051	0.00051	CbGpPWpGaD
Doxepin—HTR6—Signaling by GPCR—CCL2—age related macular degeneration	0.000508	0.000508	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—CCL2—age related macular degeneration	0.000504	0.000504	CbGpPWpGaD
Doxepin—ADRA1B—GPCR downstream signaling—C3—age related macular degeneration	0.000504	0.000504	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.000501	0.000501	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—C3—age related macular degeneration	0.0005	0.0005	CbGpPWpGaD
Doxepin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—C3—age related macular degeneration	0.000498	0.000498	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000493	0.000493	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.00049	0.00049	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—LIPC—age related macular degeneration	0.000485	0.000485	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.00048	0.00048	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—CCL2—age related macular degeneration	0.000479	0.000479	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—C3—age related macular degeneration	0.000478	0.000478	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFBR1—age related macular degeneration	0.000477	0.000477	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFBR1—age related macular degeneration	0.000469	0.000469	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CETP—age related macular degeneration	0.000468	0.000468	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—APOE—age related macular degeneration	0.000465	0.000465	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—C3—age related macular degeneration	0.000465	0.000465	CbGpPWpGaD
Doxepin—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000463	0.000463	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—CCL2—age related macular degeneration	0.000459	0.000459	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—C3—age related macular degeneration	0.000457	0.000457	CbGpPWpGaD
Doxepin—HTR2A—GPCR downstream signaling—C3—age related macular degeneration	0.000457	0.000457	CbGpPWpGaD
Doxepin—HRH1—GPCR downstream signaling—C3—age related macular degeneration	0.000456	0.000456	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—KDR—age related macular degeneration	0.000456	0.000456	CbGpPWpGaD
Doxepin—CHRM1—GPCR downstream signaling—C3—age related macular degeneration	0.000455	0.000455	CbGpPWpGaD
Doxepin—CHRM3—GPCR downstream signaling—C3—age related macular degeneration	0.000453	0.000453	CbGpPWpGaD
Doxepin—CHRM2—GPCR downstream signaling—C3—age related macular degeneration	0.000449	0.000449	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000448	0.000448	CbGpPWpGaD
Doxepin—ADRA1A—GPCR downstream signaling—C3—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000447	0.000447	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000444	0.000444	CbGpPWpGaD
Doxepin—ADRA2B—Hemostasis—VEGFA—age related macular degeneration	0.000436	0.000436	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000433	0.000433	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—SQSTM1—age related macular degeneration	0.000432	0.000432	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—CCL2—age related macular degeneration	0.000431	0.000431	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000426	0.000426	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—SQSTM1—age related macular degeneration	0.000425	0.000425	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000425	0.000425	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000423	0.000423	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000422	0.000422	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000418	0.000418	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000417	0.000417	CbGpPWpGaD
Doxepin—ADRA2A—GPCR downstream signaling—C3—age related macular degeneration	0.000416	0.000416	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—C3—age related macular degeneration	0.000415	0.000415	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—C3—age related macular degeneration	0.000414	0.000414	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—C3—age related macular degeneration	0.000413	0.000413	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—C3—age related macular degeneration	0.000411	0.000411	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000408	0.000408	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—C3—age related macular degeneration	0.000407	0.000407	CbGpPWpGaD
Doxepin—ADRA2C—Hemostasis—VEGFA—age related macular degeneration	0.000407	0.000407	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—C3—age related macular degeneration	0.000406	0.000406	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.000404	0.000404	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000395	0.000395	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000392	0.000392	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—CCL2—age related macular degeneration	0.000391	0.000391	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—CCL2—age related macular degeneration	0.000389	0.000389	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000387	0.000387	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000386	0.000386	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000385	0.000385	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000384	0.000384	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—C3—age related macular degeneration	0.000383	0.000383	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000383	0.000383	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000379	0.000379	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—C3—age related macular degeneration	0.000378	0.000378	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000376	0.000376	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000374	0.000374	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—CCL2—age related macular degeneration	0.000364	0.000364	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—C3—age related macular degeneration	0.000362	0.000362	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00036	0.00036	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—CCL2—age related macular degeneration	0.000358	0.000358	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—APOE—age related macular degeneration	0.000357	0.000357	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000351	0.000351	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—C3—age related macular degeneration	0.00035	0.00035	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—KDR—age related macular degeneration	0.00035	0.00035	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000349	0.000349	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—CD36—age related macular degeneration	0.000347	0.000347	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—C3—age related macular degeneration	0.000346	0.000346	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000344	0.000344	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—APOE—age related macular degeneration	0.000337	0.000337	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000336	0.000336	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000332	0.000332	CbGpPWpGaD
Doxepin—ADRA2A—Hemostasis—VEGFA—age related macular degeneration	0.000331	0.000331	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.00033	0.00033	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—KDR—age related macular degeneration	0.00033	0.00033	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—APOE—age related macular degeneration	0.000326	0.000326	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—C3—age related macular degeneration	0.000326	0.000326	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000325	0.000325	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—CCL2—age related macular degeneration	0.000324	0.000324	CbGpPWpGaD
Doxepin—HRH4—Signaling Pathways—VEGFA—age related macular degeneration	0.000324	0.000324	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CETP—age related macular degeneration	0.000324	0.000324	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—CCL2—age related macular degeneration	0.000323	0.000323	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—APOE—age related macular degeneration	0.000322	0.000322	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—CCL2—age related macular degeneration	0.000322	0.000322	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—KDR—age related macular degeneration	0.000319	0.000319	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—CCL2—age related macular degeneration	0.000319	0.000319	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—CCL2—age related macular degeneration	0.000318	0.000318	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000316	0.000316	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—KDR—age related macular degeneration	0.000316	0.000316	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000314	0.000314	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000308	0.000308	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—CD36—age related macular degeneration	0.000307	0.000307	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—APOE—age related macular degeneration	0.000306	0.000306	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000305	0.000305	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—APOE—age related macular degeneration	0.000303	0.000303	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000303	0.000303	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CCL2—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KDR—age related macular degeneration	0.000297	0.000297	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—CCL2—age related macular degeneration	0.000295	0.000295	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—C3—age related macular degeneration	0.000294	0.000294	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000284	0.000284	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CCL2—age related macular degeneration	0.000283	0.000283	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—C3—age related macular degeneration	0.000282	0.000282	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—CD36—age related macular degeneration	0.000281	0.000281	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—C3—age related macular degeneration	0.000275	0.000275	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CCL2—age related macular degeneration	0.000274	0.000274	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—APOE—age related macular degeneration	0.000274	0.000274	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CCL2—age related macular degeneration	0.000271	0.000271	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—APOE—age related macular degeneration	0.000271	0.000271	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—C3—age related macular degeneration	0.00027	0.00027	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KDR—age related macular degeneration	0.000268	0.000268	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000268	0.000268	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000264	0.000264	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—APOE—age related macular degeneration	0.000263	0.000263	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KDR—age related macular degeneration	0.000257	0.000257	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—APOE—age related macular degeneration	0.000256	0.000256	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CCL2—age related macular degeneration	0.000255	0.000255	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—APOE—age related macular degeneration	0.000252	0.000252	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—VEGFA—age related macular degeneration	0.000251	0.000251	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KDR—age related macular degeneration	0.00025	0.00025	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000249	0.000249	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—APOE—age related macular degeneration	0.000248	0.000248	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KDR—age related macular degeneration	0.000246	0.000246	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—C3—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—C3—age related macular degeneration	0.000245	0.000245	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—C3—age related macular degeneration	0.000244	0.000244	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—C3—age related macular degeneration	0.000243	0.000243	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—C3—age related macular degeneration	0.000241	0.000241	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—C3—age related macular degeneration	0.00024	0.00024	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000232	0.000232	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CCL2—age related macular degeneration	0.00023	0.00023	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—APOE—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—APOE—age related macular degeneration	0.000228	0.000228	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000227	0.000227	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—APOE—age related macular degeneration	0.000227	0.000227	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—APOE—age related macular degeneration	0.000226	0.000226	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—APOE—age related macular degeneration	0.000224	0.000224	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KDR—age related macular degeneration	0.000224	0.000224	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—APOE—age related macular degeneration	0.000223	0.000223	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KDR—age related macular degeneration	0.000223	0.000223	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—C3—age related macular degeneration	0.000223	0.000223	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KDR—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KDR—age related macular degeneration	0.000222	0.000222	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCL2—age related macular degeneration	0.000221	0.000221	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KDR—age related macular degeneration	0.00022	0.00022	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KDR—age related macular degeneration	0.000219	0.000219	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCL2—age related macular degeneration	0.000215	0.000215	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCL2—age related macular degeneration	0.000211	0.000211	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—APOE—age related macular degeneration	0.000208	0.000208	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000207	0.000207	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KDR—age related macular degeneration	0.000203	0.000203	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CETP—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000199	0.000199	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000195	0.000195	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—CD36—age related macular degeneration	0.000195	0.000195	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—age related macular degeneration	0.000193	0.000193	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL2—age related macular degeneration	0.000192	0.000192	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL2—age related macular degeneration	0.000191	0.000191	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL2—age related macular degeneration	0.000191	0.000191	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL2—age related macular degeneration	0.00019	0.00019	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL2—age related macular degeneration	0.000188	0.000188	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL2—age related macular degeneration	0.000188	0.000188	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—CD36—age related macular degeneration	0.000183	0.000183	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000182	0.000182	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—age related macular degeneration	0.000182	0.000182	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000176	0.000176	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000176	0.000176	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL2—age related macular degeneration	0.000175	0.000175	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—age related macular degeneration	0.000174	0.000174	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—APOE—age related macular degeneration	0.000172	0.000172	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—age related macular degeneration	0.000164	0.000164	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000162	0.000162	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—APOE—age related macular degeneration	0.00016	0.00016	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000155	0.000155	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—age related macular degeneration	0.000148	0.000148	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000143	0.000143	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000142	0.000142	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—age related macular degeneration	0.000138	0.000138	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000137	0.000137	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—age related macular degeneration	0.000136	0.000136	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000125	0.000125	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000123	0.000123	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—age related macular degeneration	0.000123	0.000123	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—age related macular degeneration	0.000123	0.000123	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—age related macular degeneration	0.000122	0.000122	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—age related macular degeneration	0.000121	0.000121	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000121	0.000121	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CD36—age related macular degeneration	0.00012	0.00012	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—age related macular degeneration	0.000112	0.000112	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—APOE—age related macular degeneration	0.000106	0.000106	CbGpPWpGaD
